Jeffrey Hrkach
Direttore Tecnico/Scientifico/R&S presso Nvelop Therapeutics, Inc.
Provenienza dei contatti di primo grado di Jeffrey Hrkach
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.
217
| College/University | Other Consumer Services | 217 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.
75
| Private Company | Investment Managers | 75 |
| Private Company | Biotechnology | 21 | |
Nvelop Therapeutics, Inc.
 Nvelop Therapeutics, Inc. Personnel ServicesCommercial Services Nvelop Therapeutics, Inc. provides staffing services. The American company was founded by David Liu, J. Keith Joung. The CEO is Thomas J. Cahill.
3
| Holding Company | Personnel Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jeffrey Hrkach tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Private Equity Investor | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Founder Director/Board Member Corporate Officer/Principal Consultant / Advisor Chief Operating Officer Chief Executive Officer Chief Executive Officer Private Equity Investor | |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Corporate Officer/Principal | |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer Founder Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Chairman Founder Director/Board Member | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Operating Officer Director/Board Member Chairman Director of Finance/CFO | |
| University of Rhode Island | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director of Finance/CFO | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Chairman | |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Chief Operating Officer | |
| EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Chief Operating Officer | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Director of Finance/CFO Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Corporate Officer/Principal | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Consultant / Advisor Founder Private Equity Investor Corporate Officer/Principal Consultant / Advisor Chief Tech/Sci/R&D Officer Private Equity Investor | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Founder Private Equity Investor | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Chairman Consultant / Advisor Founder Director/Board Member Founder Corporate Officer/Principal | |
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Private Equity Investor Chief Executive Officer | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chairman Founder Chief Executive Officer Founder Consultant / Advisor | |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Chairman Private Equity Investor | |
| VIGIL NEUROSCIENCE, INC. | Biotechnology | Chief Executive Officer Chairman Private Equity Investor Director/Board Member | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member President Chief Executive Officer Founder Director/Board Member | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Executive Officer Founder Consultant / Advisor | |
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chief Invt Officer-Spezialfond | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Analyst Private Equity Investor |
Statistiche
Distribuzione geografica
| Stati Uniti | 50 |
Settori
| Health Technology | 37 |
| Consumer Services | 9 |
| Finance | 4 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 631 |
| Corporate Officer/Principal | 235 |
| Independent Dir/Board Member | 133 |
| Chief Executive Officer | 119 |
| Chairman | 114 |
Contatti più connessi
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Amir Nashat | 49 |
| Jean-Francois Formela | 48 |
| Manu Kumar | 44 |
| Bruce Booth | 40 |
| Ryan Moore | 38 |
| Christopher Lynch | 38 |
| John Maraganore | 38 |
| Peter Barrett | 38 |
| Kevin Bitterman | 36 |
| Jacques Benkoski | 35 |
| Daniel Lynch | 32 |
| Edward Hu | 29 |
| Mark Iwicki | 26 |
| Charles Rowland | 25 |
- Borsa valori
- Insiders
- Jeffrey Hrkach
- Connessioni Società
